68Ga-PSMA PET/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer

S Klingenberg, MR Jochumsen, BP Ulhøi… - Journal of Nuclear …, 2021 - Soc Nuclear Med
With the largest high-risk prostate cancer (PCa) cohort to date undergoing 68Ga-prostate-
specific membrane antigen (PSMA) PET/CT primary staging, we aimed to, first, characterize …

Risk of metastatic disease on 68gallium‐prostate‐specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 …

JW Yaxley, S Raveenthiran, FX Nouhaud… - BJU …, 2019 - Wiley Online Library
Objective To determine the number of men with 68gallium‐prostate‐specific membrane
antigen positron emission tomography/computed tomography (68Ga‐PSMA PET/CT) avid …

Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis

CH Suh, AB Shinagare, AM Westenfield, NH Ramaiya… - Clinical Radiology, 2018 - Elsevier
Aim To evaluate the yield of staging bone scintigraphy in patients with treatment-naive
prostate cancer. Materials and methods A computerised search of the MEDLINE and …

Comparing 99mTc-PSMA to 99mTc-MDP in prostate cancer staging of the skeletal system

J Kabunda, L Gabela, C Kalinda, C Aldous… - Clinical Nuclear …, 2021 - journals.lww.com
Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging... : Clinical Nuclear
Medicine Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal …

Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy

F Arsenault, JM Beauregard… - Current Opinion in …, 2018 - journals.lww.com
PSMA-targeted tracers have shown unprecedented accuracy to stage and restage PCa
using PET/CT. Given their specific biodistribution toward PCa tissue, PSMA RLT now offers …

[PDF][PDF] Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts

KJ Donohoe, EJ Cohen, F Giammarile, E Grady… - 2017 - Soc Nuclear Med
Nuclear medicine imaging studies are essential to the diagnosis and management of many
diseases, including neoplastic disease (1). Modern imaging studies allow noninvasive …

Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis

HA Vargas, R Schor-Bardach, N Long, AN Kirzner… - Abdominal …, 2017 - Springer
Purpose Bone lesions on prostate MRI often raise concern about metastases. This study
aimed to evaluate the prevalence of bone metastases on staging prostate MRI and evaluate …

18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels< 2.00 ng/mL

D Garza, A Kandathil, Y Xi… - Nuclear Medicine …, 2021 - journals.lww.com
Objective To establish the detection rate of prostate cancer recurrence following definitive
therapy by 18 F-fluciclovine PET/computed tomography (CT) in patients with biochemical …

Safely omitting bone isotope scans in a cohort of grade group 2 prostate cancer

A Mustaffa, S Emara - The Prostate, 2023 - Wiley Online Library
Objective A retrospective review conducted in our urology unit to assess the efficiency for
requesting bone scans for newly diagnosed prostate cancer patients, aiming to minimize …

[PDF][PDF] Association of PSA with bone scan in carcinoma prostate

KC Rohra, RH Mangrio, AA Shaikh, B Suria… - Rawal Medical …, 2022 - rmj.org.pk
Objective: To see the relation of PSA> 20 ng/dl with bone metastasis. Methodology: This is
prospective study includes fifty patient who were newly diagnosed with PSA> 20 ng/dl …